Cancerous gestational trophoblastic disease

A cancerous (malignant) tumour can grow into nearby tissue and destroy it. The cancer cells can also spread (metastasize) to other parts of the body.

Gestational trophoblastic disease (GTD) is usually non-cancerous (benign). But in rare cases abnormal trophoblastic cells can form a cancerous tumour or a non-cancerous hydatidiform mole can become cancerous. Cancerous GTD is also called gestational trophoblastic neoplasia (GTN).

Invasive mole

An invasive mole is a cancerous tumour made up of abnormal trophoblast cells that have grown into the muscle wall of the uterus (called the myometrium).

This type of cancerous GTD can sometimes develop from a hydatidiform mole. Invasive moles can also develop if abnormal trophoblast cells are left behind after surgery to remove a hydatidiform mole. An invasive mole that develops after a hydatidiform mole is removed may be called a persistent mole or persistent trophoblastic disease.

Invasive moles usually need to be treated, but sometimes they go away on their own. Although invasive moles are cancerous, they rarely spread out outside of the uterus. Even if an invasive mole spreads, it can often be successfully treated.

Gestational choriocarcinoma

Gestational choriocarcinoma is a rare cancerous type of GTD. It can develop from trophoblast tissue left in the uterus after a miscarriage, an abortion, or a normal pregnancy.

In rare cases, a choriocarcinoma can develop from germ cells (egg cells in the ovary or sperm cells in the testicle) rather than trophoblast cells. These are types of germ cell tumours called non-gestational choriocarcinomas. Find out more about cancerous tumours of the ovary and cancerous tumours of the testicle.

A gestational choriocarcinoma can grow into the muscle wall of the uterus and nearby blood vessels. It can also spread to other parts of the body, such as the lungs, vagina, brain or liver. In rare cases, it can spread to the skin, gastrointestinal (GI) tract, kidneys, breasts or bone.

Placental site trophoblastic tumour

A placental site trophoblastic tumour (PSTT) is a rare and slow-growing cancerous type of GTD. PSTTs are usually found months or years after they start to develop. PSTT starts where the placenta attaches to the wall of the uterus. These tumours can grow into the muscle wall of the uterus, but they usually don't spread to other parts of the body. Most PSTTs develop after a normal pregnancy. They can also occur after a miscarriage, an abortion or removal of a hydatidiform mole.

Epithelioid trophoblastic tumour

Epithelioid trophoblastic tumours (ETTs) are the rarest type of cancerous GTD. They most often develop after a normal pregnancy. These tumours usually occur in the uterus, but they can sometimes be found in the cervix. It can take several years for ETT to develop. So it may not cause any signs or symptoms for a long time. As a result, this type of cancer may have spread to other parts of the body (called distant metastasis) when it is diagnosed.

Expert review and references

  • Guideline Resource Unit (GURU). Gestational Trophoblastic Neoplasia. Edmonton: Alberta Health Services; 2021: Clinical Practice Guideline GYNE-008 – Version 2. https://www.albertahealthservices.ca/info/cancerguidelines.aspx.
  • Gestational Trophoblastic Neoplasia. Provincial Health Services Authority. Gestational Trophoblastic Neoplasia. Vancouver, BC: 2021. https://www.bccancer.bc.ca/. February 20, 2024.
  • Ross S. Berkowitz Neil S. Horowitz Donald P. Goldstein Berek, Jonathan; Hacker, Neville F.. Gestational Trophoblastic Disease. Berek JS, Hacker NF (eds.). Berek and Hacker's Gynecologic Oncology. 7th ed. Philadelphia: Wolters Kluwer; 2021: p 562-580.
  • American Society of Clinical Oncology (ASCO). Cancer.net: Gestational Trophoblastic Disease: Introduction. February 20, 2024.
  • Cancer Research UK. What is gestational trophoblastic disease?. https://www.cancerresearchuk.org/. February 20, 2024.
  • Ross S. Berkowitz, Kevin M. Elias, and Neil S. Horowitz DeVita, Jr Vincent T; Rosenberg, Steven A; Lawrence, Theodore S.. Gestational Trophoblastic Neoplasia. DeVita VT Jr, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2015: 75: 1069-1074.
  • National Cancer Institute. Gestational Trophoblastic Disease Treatment (PDQ®)–Patient Version. National Institutes of Health; https://www.cancer.gov/. February 20, 2024.

Your trusted source for accurate cancer information

With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2025 Canadian Cancer Society